Insulin Autoimmune Syndrome (IAS): Evidence‑Based Diagnostic and Therapeutic Guidelines

Diagnostic Criteria

• Recurrent hypoglycemia with plasma glucose < 55 mg/dL, insulin concentrations > 100 µU/mL, insulin‑autoantibody titers ≥ 0.4 U/mL, and no prior exposure to exogenous insulin are required for diagnosis【1】.
• During hypoglycemia, insulin levels are typically > 75 µU/mL (often 100–300 µU/mL) because antibody‑insulin complexes interfere with immunoassays【1】.
• C‑peptide values > 9.6 ng/mL strongly favor IAS over other causes of hyperinsulinemic hypoglycemia【1】.
• Proinsulin ≥ 5.0 pmol/L and β‑hydroxybutyrate ≤ 2.7 mmol/L support endogenous hyperinsulinism and help differentiate IAS from factitious hypoglycemia【2】.
• Screening for sulfonylureas or glinides is mandatory to exclude factitious hypoglycemia【2】.

Clinical Pattern and Testing

• Hypoglycemia characteristically occurs 3–5 hours after meals (late post‑prandial period) rather than during fasting【3】.
• A mixed‑meal tolerance test with blood sampling every 30 minutes for up to 300 minutes is the preferred diagnostic procedure for post‑prandial hypoglycemia【3】.

Risk Factors Prompting Evaluation

• Recent use of sulfhydryl‑containing drugs (e.g., methimazole, penicillamine, captopril, clopidogrel) should trigger testing for IAS【1】.
• Proton‑pump inhibitor therapy (e.g., omeprazole) is an increasingly recognized precipitant【1】.
• Asian ethnicity (particularly Japanese or Korean descent), female gender, and co‑existing autoimmune diseases increase suspicion for IAS【1】.

Diagnostic Pitfalls

• Insulin values > 100 µU/mL often reflect assay interference from insulin‑antibody complexes; immediate insulin‑antibody testing is advised【1】.
• Oral glucose tolerance tests are unsuitable for evaluating post‑prandial hypoglycemia; mixed‑meal testing must be used【1】【3】.
• Point‑of‑care glucose meters are insufficient for diagnosis; laboratory plasma glucose measurement is required【1】.
• Insulin‑antibody testing can be performed after the acute episode; repeat testing during separate episodes is unnecessary【1】【3】.

Differential Diagnosis

First‑Line Management

• Immediately discontinue sulfhydryl‑containing medications and proton‑pump inhibitors【1】.
• Implement six small, frequent meals daily emphasizing complex carbohydrates, high fiber, and avoidance of simple sugars【1】【4】.
• Avoid liquids within 30 minutes of solid meals to slow gastric emptying【1】【4】.
• Provide bedtime uncooked cornstarch to supply sustained glucose release for nocturnal hypoglycemia【1】.

Pharmacologic Escalation (Severe or Refractory Cases)

• Calcium‑channel blockers (nifedipine, verapamil) have demonstrated efficacy in patients unresponsive to dietary measures【1】.
• Octreotide (somatostatin analogue) is recommended for patients who fail both dietary therapy and calcium‑channel blockers【1】.

Extreme Measures

• Continuous enteral feeding or intragastric glucose infusion may be required when pharmacologic therapy is insufficient to prevent hypoglycemia【1】【3】.

Critical Management Pitfall

• Pancreatectomy is contraindicated for IAS because hypoglycemia is mediated by circulating autoantibodies, not pancreatic pathology【1】.

Prognosis

• Disease severity ranges from mild (controlled with dietary modification) to severe (requiring continuous glucose infusion)【1】【3】.

• IAS is frequently self‑limiting, with many patients achieving spontaneous remission over months to years, although high‑titer insulin antibodies may persist despite clinical improvement【1】.

Diagnostic and Prognostic Evidence for Insulin Autoimmune Syndrome

Laboratory Confirmation of Hypoglycemia

• During a suspected hypoglycemic episode, obtain a laboratory‑measured plasma glucose (rather than a point‑of‑care meter) while glucose is documented < 55 mg/dL (3.0 mmol/L). 5

Insulin Antibody Assessment

• Insulin‑antibody testing can be performed after the acute hypoglycemic episode; repeating the assay during separate episodes is unnecessary. 5

Mixed‑Meal Tolerance Test (MMTT) for Postprandial Hypoglycemia

• The preferred provocative test is a mixed‑meal tolerance test that provides a meal containing 50–60 % carbohydrate; glucose, insulin, C‑peptide, and proinsulin should be measured every 30 minutes for up to 300 minutes to capture the post‑prandial pattern. 5

Natural History and Prognosis

• Insulin autoimmune syndrome is frequently self‑limiting, with many patients achieving spontaneous remission over months to years. 6

Misinterpretation of Isolated Insulin Antibody Positivity

Diagnostic Pitfalls

• Low‑titer insulin antibodies (present in 1–2 % of healthy individuals) without concurrent hypoglycemia and hyperinsulinemia should not be considered diagnostic for insulin autoimmune syndrome; relying on such isolated antibody positivity can lead to misdiagnosis. 7